Metsera, Inc..
MTSR.US | Other professional, scientific and technical activities n.e.c.
I am unable to provide a company description as the provided information is insufficient to determine the company's activities. The company name and ticker symbol (MTSR.US) are not enough to accurately classify its business. More information about Metsera, Inc.'s products, services, or industry is n...Show More
Better Health for All
30
Metsera is a clinical-stage biotechnology company focused on developing therapies for obesity and related diseases, with its entire business devoted to health improvement.
1
Clinical trials for its drug candidates have shown significant positive health impacts, including up to 11.3% mean placebo-adjusted weight loss for MET-097i over 12 weeks and up to 8.4% placebo-subtracted mean weight loss for MET-233i at Day 36.
2
The company has no revenue from products with negative health impacts, having been founded in early 2022.
3
Safety records from trials show no severe or serious adverse events, with gastrointestinal events being mild, moderate, and short-lived.
4
The company has raised over $500 million in funding, indicating substantial investment in health innovation.
5
Clinical trials are described as randomized, placebo-controlled, and double-blind, suggesting adherence to ethical standards.
6
Fair Money & Economic Opportunity
0
No evidence available to assess Metsera, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
The company has no public record of labor-law breaches, regulatory actions, violations, or fines mentioned in the provided information.
1
Fair Trade & Ethical Sourcing
0
No evidence available to assess Metsera, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No data was available from the provided article to assess Metsera, Inc. against the 'Honest & Fair Business' ethical value.
1
The article explicitly stated that no data could be retrieved for analysis.
2
Kind to Animals
0
No specific, quantifiable evidence was found in the provided articles regarding Metsera, Inc.'s performance on any of the 'Kind to Animals' key performance indicators. The articles discuss the company's focus on developing therapies for obesity and metabolic diseases, including preclinical and clinical studies,
1
but do not provide details on animal testing policies, volumes, alternative testing methods, certifications, or any other animal welfare-related practices specific to Metsera, Inc.
2
No War, No Weapons
0
No evidence available to assess Metsera, Inc. on No War, No Weapons.
Planet-Friendly Business
0
No evidence was found in the provided articles to assess Metsera, Inc. against any of the 'Planet-Friendly Business' KPIs.
1
The articles explicitly state that no relevant sustainability or environmental data is present or available for the company.
2
Respect for Cultures & Communities
0
The provided articles primarily focus on Metsera, Inc.'s financial performance, clinical trial results, and an ongoing acquisition battle. No specific information or data points were found regarding the company's engagement with indigenous or local community groups, cultural preservation efforts, local employment, grievance mechanisms, or any other metrics directly related to the 'Respect for Cultures & Communities' value.
1
2
3
4
Safe & Smart Tech
0
Metsera's Privacy Policy, last updated January 6, 2025, explicitly states that the company does not sell any Personal Data and has not sold any in the past.
1
The company also states that it keeps data only as long as necessary to fulfill contractual, regulatory, and statutory obligations.
2
Metsera complies with GDPR for EEA/UK residents and CCPA for California residents, providing data subject rights such as access, amendment, deletion, restriction of processing, and data transfer.
3
Users can control most cookies through their browser settings, and the company uses only cookies necessary for website functionality, with session cookies lasting 2 hours.
4
Metsera makes reasonable efforts to ensure Personal Data is kept secure and accessed only by authorized employees.
5
The company does not track users across third-party websites for targeted advertising and does not respond to Do Not Track signals.
6
Zero Waste & Sustainable Products
0
No specific, concrete evidence was found in the provided articles regarding Metsera, Inc.'s performance on any of the 'Zero Waste & Sustainable Products' KPIs. The articles primarily focus on the company's acquisition by Pfizer, financial details, and drug development pipeline for obesity treatments. There is no information on waste diversion rates, product recyclability, packaging sustainability, recycled content, waste reduction initiatives, or any other related metrics.
1
The single mention of 'sustainable' in one article refers to treatment strategies, not environmental product or waste management practices.
2